TEL: (888) 907-0115
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
Treat discoloration and other signs of premature aging without surgery or downtime
Time makes its mark on the skin, leaving any number of damages, including pigmentation changes, uneven texture, and vascular lesions. Today, many consumers are frustrated by premature skin aging and want to do something about it. In fact, a 2018 consumer survey conducted by the American Society for Dermatologic Surgery (ASDS) revealed that a remarkable 73% of respondents are bothered by two common signs of premature aging: discoloration and/or uneven skin texture. The same survey showed that almost 70% of these consumers are considering a cosmetic procedure1. This means there is a ready market of customers looking for the changes that a photorejuvenation machine can provide.
By incorporating Venus Concept’s IPL-based photorejuvenation equipment into your suite of services, you'll be able to offer your patients a safe, comfortable, and effective solution for premature skin aging with no surgery or downtime—exactly what they're looking for. This paves the way for high patient satisfaction, which, combined with Venus Concept's unique business model, enables higher revenue potential for your practice.
As a doctor or aesthetician, consider adding the Venus Versa™ photorejuvenation/photofacial machine to your clinic’s offerings. You could increase the success of your business and enhance your overall practice by giving patients a safe, reliable way to counteract the effects of sun damage on the skin. Through IPL technology, our devices deliver direct bursts of energy onto targeted areas of the skin to treat both pigmented and vascular lesions. To maximize comfort for patients, our IPL photorejuvenation device uses Smartpulse™ technology and a real-time cooling system to provide precise and consistent energy delivery with no downtime. In other words, the Venus Versa™ IPL system can help enable you to provide patients with safety and comfort alongside promising results. To learn more about Venus Concept’s IPL photorejuvenation machine options, contact us today.
A versatile multi-applicator platform with three different, highly effective technologies in one workstation to address all of today's most challenging aesthetic concerns. Choose from two different professional IPL photorejuvenation/photofacial applicators with varying wavelengths to treat a wider range of skin conditions.
Fade the appearance of various vascular and pigmented lesions, including hyperpigmentation, melasma, port wine stains, hemangiomas, telangiectasias, venous malformations, and more.
Devices that offer photorejuvenation: Venus Versa™
Results after: 1 treatment
Courtesy of Tal Nachlieli, MD
Fade the appearance of various vascular and pigmented lesions, including hyperpigmentation, melasma, port wine stains, hemangiomas, telangiectasias, venous malformations, and more.
Devices that offer photorejuvenation: Venus Versa™
Results after: 1 treatment
Courtesy of Tal Nachlieli, MD
INDICATIONS FOR USE:
*Venus Versa™ is cleared by the FDA as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are cleared by the FDA for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are cleared by the FDA for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is cleared by the FDA for the treatment of acne vulgaris. The DiamondPolar™ and OctiPolar™ applicators on the Venus Versa™ system are cleared by the FDA for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The NanoFractional RF™ (Viva) applicator is cleared by the FDA for dermatological procedures requiring ablation and resurfacing of the skin.
REFERENCES:
1. American Society for Dermatologic Surgery (ASDS) 2018 Consumer Survey on Cosmetic Dermatologic Procedures. Data were collected from 3,525 consumers through a blind online survey in 2018.
To book a consultation or a demo, please contact us by clicking the button below and a representative will reach out to you directly.
For more information call: (888) 907-0115 // info@venusconcept.com // 1880 N Commerce Parkway, Suite 2, Weston, FL, 33326 United States
REGULATORY CLEARANCES [ More ]
Venus Bliss™ is cleared by the FDA for non-invasive lipolysis of the abdomen and flanks in individuals with a Body Mass Index (BMI) of 30 or less, with the diode laser applicators. The (MP)2 applicator is cleared by the FDA for temporary reduction in the appearance of cellulite.
Venus Versa™ is cleared by the FDA as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are cleared by the FDA for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are cleared by the FDA for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is cleared by the FDA for the treatment of acne vulgaris. The DiamondPolar™ and OctiPolar™ applicators on the Venus Versa™ system are cleared by the FDA for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The NanoFractional RF™ (Viva) applicator is cleared by the FDA for dermatological procedures requiring ablation and resurfacing of the skin.
ARTAS iX™ is cleared by the FDA with indication for use for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair. ARTAS iX™ is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation; creating recipient sites; and implanting harvested hair follicles.
NeoGraft® is cleared by the FDA with indication for use in suction-assisted follicular extraction and re-implantation. NeoGraft® is an auto-graft system and can be used on both male and female patients.
Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV with the OctiPolar™ and DiamondPolar™ applicators, and temporary reduction in the appearance of cellulite with the 4D Body (LB2) and 4D Face (LF2) applicators.
Venus Velocity™ is cleared by the FDA for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae, for all Fitzpatrick skin types.
The Venus Viva™ MD is cleared by the FDA for the use in dermatological procedures requiring ablation and resurfacing of the skin, and the non-invasive treatment of moderate to severe facial wrinkles and rhytides for females in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.
Venus Freeze Plus™ is a non-invasive device cleared by the FDA for use in dermatologic and general surgical procedures for females for the treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV, using the DiamondPolar™ and OctiPolar™ applicators.
Venus Heal™ is cleared by the FDA for the relief of minor muscle aches and pain, relief of muscle spasm, and temporary improvement of local blood circulation. The treatment of these conditions will lead to the treatment of certain soft tissue injuries and conditions.
Venus Glow™ is cleared by the FDA as a Class I motorized dermabrasion device. It provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Venus Epileve™ is cleared by the FDA for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs
re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types.
Copyright © 2020 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click HereBe aware of schemes involving fraudulent job postings.
Read More